An independent ecosystem briefing built by Bracken, supporting SNMMI 2026.The Bracken Group
← All speakers
plenary

Vasken Dilsizian

Professor of Medicine and Radiology, Chief, Division of Nuclear Medicine

University of Maryland School of Medicine

Speaking at SNMMI 2026plenary
Session

2026 Henry N. Wagner, Jr., MD Lectureship — Nuclear Cardiac Imaging: From Legacy to Innovation

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

Smart questions to ask

If you get five minutes with the speaker

  1. How is your team thinking about the cyclotron-versus-reactor tradeoff for short-half-life isotopes?
  2. What's the regulatory inflection that worries you most for the next 24 months?
  3. How much of the AI tooling on the floor would you trust in a regulated reading workflow today?

Generated by a mock model. Wired to Anthropic when the API key is in place.

Recent activity

What we're seeing

  • STAT News · 2026-08-25
    Vasken Dilsizian delivers keynote at International Theranostics Congress
    Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
  • Imaging Wire · 2026-03-06
    Vasken Dilsizian comments on FDA guidance for radiopharmaceutical trials
    Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
  • PR Newswire · 2026-06-27
    Vasken Dilsizian joins editorial board of European Journal of Nuclear Medicine
    Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
  • Nuclear Medicine Today · 2026-09-04
    Vasken Dilsizian cited in NEJM perspective on theranostic standardization
    Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
  • Endpoints News · 2026-04-13
    Vasken Dilsizian co-authors review on PSMA in Journal of Nuclear Medicine
    Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

Bracken's POV on this work

A short editorial paragraph from Bracken's radiopharma team, framing why this plenary topic matters for sponsors and what we'd watch in the next 18 months.

Meet Bracken at SNMMI